Proposed legislation would give marine regulator antitrust powers

This article originally appeared on Cargomatic.com

proposed legislation

MAY 10, 2023 — U.S. Representative John Garamendi has introduced legislation aimed at giving the Federal Maritime Commission (FMC) the power to undertake antitrust investigations of vessel sharing agreements (VSAs) among ocean carriers.

The bill aims to strengthen the Ocean Shipping Reform Act of 2022 (OSRA 22), which has given the FMC greater powers to scrutinize the ocean carrier industry.

However, OSRA 22 did not have any provision that would enable the FMC to undertake antitrust investigations into VSAs, which have long raised suspicions of collusion in government circles.

The proposed law does not seek to ban ocean carrier alliances, but only to speed up the investigatory process for shippers who suspect their charges may have been illegally increased by collusion between carriers.

Currently, the FMC is required by law to seek a Federal Court Order before it can block what may be an anticompetitive agreement between two or more ocean carriers.

The proposed legislation would enable the FMC to bypass that step and undertake antitrust investigations without Court approval.

“This bipartisan bill would allow the FMC to block any agreements among ocean carriers and marine terminal operators determined to be unreasonably anticompetitive without having to first obtain a federal court order,” Mr. Garamendi’s office said.

But John Butler, President and Chief Executive of the World Shipping Council, opposed Mr Garamendi’s proposal, saying that “nobody has offered a reason why we should throw away such a useful tool as vessel sharing arrangements.”

He suggested that some of “the rhetoric comes from a misunderstanding about how VSAs help the supply chain work better” and that “we look forward to working with the bill’s sponsors to better understand their policy objectives.”

The proposed legislation was welcomed by Federal Maritime Commissioners Max Vekich and Carl W. Bentzel, who had jointly requested that the U.S. House Committee on Transportation and Infrastructure make this change in federal law.

Commissioner Bentzel referred to the bill as a “vital fix” while Commissioner Vekich said it will “simplify the process” by which the FMC reviews agreements among ocean carriers.

https://cargomatic.com/

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More